Skip to main content
EN
Caution:
At present, there are occasional discrepancies in the display of intellectual property rights holders and their representatives. We are working on a solution.
Patent Search
Details
see.ip - Details for VERWENDUNG VON RILUZOL, RILUZOLPRODRUGS ODER RILUZOLANALOGA MIT IMMUNTHERAPIEN ZUR BEHANDLUNG VON KREBS
Details for 2017800310
Up to date per 11.06.2026
Actions
Copy link to European Patent
Download Registration Print
Details
Details for 2017800310
Title / Product Name
VERWENDUNG VON RILUZOL, RILUZOLPRODRUGS ODER RILUZOLANALOGA MIT IMMUNTHERAPIEN ZUR BEHANDLUNG VON KREBS
Status
Granted/Registered
Protection Type
European Patent
(AT-) Application Number
2017800310
EP Publication Number
3458053
E-Number
1453233
Language
EN
PCT Number
US17033688
Publication Date
27.03.2019 A
08.12.2021 B1
Registration Date
08.12.2021
AT Publication Date
15.12.2021
Application Date
19.05.2017
Registration Number
-
Priorities
20.05.2016
US
201662339433 P
IPC
A61K 31/428 20060101AFI20191016BHEP
Maximum Duration of Protection
19.05.2037
Owner
Biohaven Therapeutics Ltd.
215 Church Street, Suite 301
New Haven, CT 06510
US
Representative
Representative
Patentanwalt Mikšovsky KG
Bisamberger Straße 19
2100 Korneuburg
AT
Inventor
CORIC, Vladimir
234 Church Street Suite 301
New Haven Connecticut 06520
US
Information about Fees
Click here to load the fees